These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 11470992)
1. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2. Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992 [TBL] [Abstract][Full Text] [Related]
2. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636 [TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976 [TBL] [Abstract][Full Text] [Related]
4. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population. Topinka J; Binková B; Mracková G; Stávková Z; Peterka V; Benes I; Dejmek J; Lenícek J; Pilcík T; Srám RJ Environ Mol Mutagen; 1997; 30(2):184-95. PubMed ID: 9329643 [TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276 [TBL] [Abstract][Full Text] [Related]
7. Coke oven workers study: the effect of exposure and GSTM1 and NAT2 genotypes on DNA adduct levels in white blood cells and lymphocytes as determined by 32P-postlabelling. Binková B; Topinka J; Mracková G; Gajdosová D; Vidová P; Stávková Z; Peterka V; Pilcík T; Rimár V; Dobiás L; Farmer PB; Srám RJ Mutat Res; 1998 Aug; 416(1-2):67-84. PubMed ID: 9725993 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung. Lee MS; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1492-7. PubMed ID: 20501762 [TBL] [Abstract][Full Text] [Related]
9. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. McGrath M; Michaud D; De Vivo I BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750 [TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698 [TBL] [Abstract][Full Text] [Related]
12. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Rojas M; Cascorbi I; Alexandrov K; Kriek E; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H Carcinogenesis; 2000 Jan; 21(1):35-41. PubMed ID: 10607731 [TBL] [Abstract][Full Text] [Related]
13. Environmental air pollution and DNA adducts in Copenhagen bus drivers--effect of GSTM1 and NAT2 genotypes on adduct levels. Nielsen PS; de Pater N; Okkels H; Autrup H Carcinogenesis; 1996 May; 17(5):1021-7. PubMed ID: 8640907 [TBL] [Abstract][Full Text] [Related]
14. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Hou SM; Lambert B; Hemminki K Carcinogenesis; 1995 Aug; 16(8):1913-7. PubMed ID: 7543377 [TBL] [Abstract][Full Text] [Related]
15. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes. Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530 [TBL] [Abstract][Full Text] [Related]
16. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722 [TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Yu MC; Ross RK; Chan KK; Henderson BE; Skipper PL; Tannenbaum SR; Coetzee GA Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):861-4. PubMed ID: 8634658 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440 [TBL] [Abstract][Full Text] [Related]
19. DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes. Pfau W; Stone EM; Brockstedt U; Carmichael PL; Marquardt H; Phillips DH Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1019-25. PubMed ID: 9829711 [TBL] [Abstract][Full Text] [Related]
20. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]